1. Home
  2. SNSE vs TGL Comparison

SNSE vs TGL Comparison

Compare SNSE & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • TGL
  • Stock Information
  • Founded
  • SNSE 2005
  • TGL 2020
  • Country
  • SNSE United States
  • TGL United States
  • Employees
  • SNSE N/A
  • TGL N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • SNSE Health Care
  • TGL Technology
  • Exchange
  • SNSE Nasdaq
  • TGL Nasdaq
  • Market Cap
  • SNSE 10.3M
  • TGL 10.7M
  • IPO Year
  • SNSE 2021
  • TGL 2022
  • Fundamental
  • Price
  • SNSE $8.60
  • TGL $0.65
  • Analyst Decision
  • SNSE Strong Buy
  • TGL
  • Analyst Count
  • SNSE 5
  • TGL 0
  • Target Price
  • SNSE $72.50
  • TGL N/A
  • AVG Volume (30 Days)
  • SNSE 39.5K
  • TGL 685.3K
  • Earning Date
  • SNSE 11-14-2025
  • TGL 11-14-2025
  • Dividend Yield
  • SNSE N/A
  • TGL N/A
  • EPS Growth
  • SNSE N/A
  • TGL N/A
  • EPS
  • SNSE N/A
  • TGL N/A
  • Revenue
  • SNSE N/A
  • TGL $2,305,713.00
  • Revenue This Year
  • SNSE N/A
  • TGL N/A
  • Revenue Next Year
  • SNSE N/A
  • TGL N/A
  • P/E Ratio
  • SNSE N/A
  • TGL N/A
  • Revenue Growth
  • SNSE N/A
  • TGL N/A
  • 52 Week Low
  • SNSE $5.00
  • TGL $0.57
  • 52 Week High
  • SNSE $18.35
  • TGL $39.00
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 44.73
  • TGL 40.70
  • Support Level
  • SNSE $8.37
  • TGL $0.57
  • Resistance Level
  • SNSE $9.42
  • TGL $0.74
  • Average True Range (ATR)
  • SNSE 1.08
  • TGL 0.07
  • MACD
  • SNSE -0.02
  • TGL -0.00
  • Stochastic Oscillator
  • SNSE 33.45
  • TGL 29.98

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About TGL Treasure Global Inc.

Treasure Global Inc. has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: (i) payment processing and e-commerce operation in its ZCITY platform, and (ii) customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

Share on Social Networks: